Showing results (11-20 of 22) with videos related to
Sort By:
Pageof 3
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|December 26, 2001
Hepatopulmonary syndrome occurring after orthotopic liver transplantationC E Avendano, P A Flume, P Baliga, et al.Antimicrobial Agents and Chemotherapy|November 26, 1997
Comparative bactericidal activity of ceftazidime against isolates of Pseudomonas aeruginosa as assessed in an in vitro pharmacodynamic model versus the traditional time-kill methodM Manduru, L B Mihm, R L White, et al.Antimicrobial Agents and Chemotherapy|September 26, 1997
In vitro pharmacodynamics of ceftazidime against Pseudomonas aeruginosa isolates from cystic fibrosis patientsM Manduru, L B Mihm, R L White, et al.American Journal of Respiratory and Critical Care Medicine|June 1, 1994
Infectious complications of lung transplantation. Impact of cystic fibrosisP A Flume, T M Egan, L J Paradowski, et al.Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|December 22, 2021
C-reactive protein (CRP) as a biomarker of pulmonary exacerbation presentation and treatment responseD R VanDevanter, S L Heltshe, M Skalland, et al.Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|August 18, 2020
Changes in symptom scores as a potential clinical endpoint for studies of cystic fibrosis pulmonary exacerbation treatmentD R VanDevanter, S L Heltshe, D B Sanders, et al.Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|April 25, 2022
Antipseudomonal treatment decisions during CF exacerbation managementD R VanDevanter, N E West, D B Sanders, et al.The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|January 1, 1994
Lung transplantation for mechanically ventilated patientsP A Flume, T M Egan, J H Westerman, et al.Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|December 3, 2021
Association of site of treatment with clinical outcomes following intravenous antimicrobial treatment of a pulmonary exacerbationD B Sanders, U Khan, S L Heltshe, et al.Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|April 26, 2017
Rationalizing endpoints for prospective studies of pulmonary exacerbation treatment response in cystic fibrosisD R VanDevanter, S L Heltshe, J Spahr, et al.Pageof 3